Statins linked with lower mortality risk in study of liver cancer

01/28/2013 | MedPage Today (free registration)

Patients with hepatocellular carcinoma who took statins, in combination with local and systemic treatments or surgical resection, had a 30% lower risk of death than non-statin users. Statin users lived for an average of 25.4 months compared with 18.5 for non-users, researchers said. The retrospective, nonrandomized study, which involved 644 patients, was presented at the Gastrointestinal Cancers Symposium.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT